Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 4
2014 4
2015 8
2016 22
2017 9
2018 12
2019 14
2020 14
2021 6
2022 16
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Update of drug-resistant tuberculosis treatment guidelines: A turning point.
Vanino E, Granozzi B, Akkerman OW, Munoz-Torrico M, Palmieri F, Seaworth B, Tiberi S, Tadolini M. Vanino E, et al. Among authors: akkerman ow. Int J Infect Dis. 2023 May;130 Suppl 1:S12-S15. doi: 10.1016/j.ijid.2023.03.013. Epub 2023 Mar 12. Int J Infect Dis. 2023. PMID: 36918080 Free article. Review.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017; Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilb… See abstract for full author list ➔ Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, et al. Among authors: akkerman ow. Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Lancet. 2018. PMID: 30215381 Free PMC article. Review.
Endobronchial tuberculosis.
Eskandari SK, Akkerman OW. Eskandari SK, et al. Among authors: akkerman ow. Lancet Infect Dis. 2024 May;24(5):e343. doi: 10.1016/S1473-3099(24)00057-4. Lancet Infect Dis. 2024. PMID: 38670683 No abstract available.
The pharmacokinetics of antibiotics in cystic fibrosis.
Akkerman-Nijland AM, Akkerman OW, Grasmeijer F, Hagedoorn P, Frijlink HW, Rottier BL, Koppelman GH, Touw DJ. Akkerman-Nijland AM, et al. Among authors: akkerman ow. Expert Opin Drug Metab Toxicol. 2021 Jan;17(1):53-68. doi: 10.1080/17425255.2021.1836157. Epub 2020 Dec 29. Expert Opin Drug Metab Toxicol. 2021. PMID: 33213220 Review.
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
Global Tuberculosis Network and TB/COVID-19 Global Study Group; Casco N, Jorge AL, Palmero DJ, Alffenaar JW, Fox GJ, Ezz W, Cho JG, Denholm J, Skrahina A, Solodovnikova V, Arbex MA, Alves T, Rabahi MF, Pereira GR, Sales R, Silva DR, Saffie MM, Salinas NE, Miranda RC, Cisterna C, Concha C, Fernandez I, Villalón C, Vera CG, Tapia PG, Cancino V, Carbonell M, Cruz A, Muñoz E, Muñoz C, Navarro I, Pizarro R, Cristina Sánchez GP, Vergara Riquelme MS, Vilca E, Soto A, Flores X, Garavagno A, Bahamondes MH, Merino LM, Pradenas AM, Revillot ME, Rodriguez P, Salinas AS, Taiba C, Valdés JF, Subiabre JN, Ortega C, Palma S, Castillo PP, Pinto M, Bidegain FR, Venegas M, Yucra E, Li Y, Cruz A, Guelvez B, Victoria Plaza R, Tello Hoyos KY, Cardoso-Landivar J, Van Den Boom M, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Gupta N, Ish P, Mishra G, Patel JM, Singla R, Udwadia ZF, Alladio F, Angeli F, Calcagno A, Centis R, Codecasa LR, De Lauretis A, Esposito SMR, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Matteelli A, Migliori GB, Motta I, Palmieri F, Pontali E, Prestileo T, Riccardi N, Sad… See abstract for full author list ➔ Global Tuberculosis Network and TB/COVID-19 Global Study Group, et al. Among authors: akkerman ow. Eur Respir J. 2023 Nov 29;62(5):2300925. doi: 10.1183/13993003.00925-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37827576 Free PMC article.
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q.
Niewold P, Dijkstra DJ, Cai Y, Goletti D, Palmieri F, van Meijgaarden KE, Verreck FAW, Akkerman OW, Hofland RW, Delemarre EM, Nierkens S, Verheul MK, Pollard AJ, van Dissel JT, Ottenhoff THM, Trouw LA, Joosten SA. Niewold P, et al. Among authors: akkerman ow. Sci Rep. 2023 Jul 18;13(1):11617. doi: 10.1038/s41598-023-38889-x. Sci Rep. 2023. PMID: 37464009 Free PMC article.
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
Bolhuis MS, van der Werf TS, Akkerman OW. Bolhuis MS, et al. Among authors: akkerman ow. N Engl J Med. 2020 Jun 11;382(24):2376-2377. doi: 10.1056/NEJMc2009939. N Engl J Med. 2020. PMID: 32521142 No abstract available.
Tuberculosis-Related Malnutrition: Public Health Implications.
Ter Beek L, Alffenaar JC, Bolhuis MS, van der Werf TS, Akkerman OW. Ter Beek L, et al. Among authors: akkerman ow. J Infect Dis. 2019 Jun 19;220(2):340-341. doi: 10.1093/infdis/jiz091. J Infect Dis. 2019. PMID: 30835281 No abstract available.
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.
Kuhlin J, Sturkenboom MGG, Ghimire S, Margineanu I, van den Elsen SHJ, Simbar N, Akkerman OW, Jongedijk EM, Koster RA, Bruchfeld J, Touw DJ, Alffenaar JC. Kuhlin J, et al. Among authors: akkerman ow. Clin Mass Spectrom. 2018 Oct 19;14 Pt A:34-45. doi: 10.1016/j.clinms.2018.10.002. eCollection 2019 Sep. Clin Mass Spectrom. 2018. PMID: 34934812 Free PMC article. Review.
116 results